I

f at first you don’t succeed …

After being rebuffed by the Obama administration, a consumer advocacy group is now asking the Trump administration to use federal law to widen access in the United States to a pricey prostate cancer drug that was developed with taxpayer funds.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.

X